APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Rilpivirine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Rilpivirine Market Outlook and Growth Opportunities 2026

Report ID 174033020423 December 2025195 pages

Choose your research edition.

Industry ResearchRilpivirine Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Rilpivirine Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Rilpivirine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rilpivirine Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Rilpivirine Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Rilpivirine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Rilpivirine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Rilpivirine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Rilpivirine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Rilpivirine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Rilpivirine market include Aspen, Gilead Sciences, Janssen Cilag International, Pharmacare Limited, Strides Pharma Science Limited and ViiV Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Rilpivirine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Rilpivirine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Rilpivirine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Rilpivirine market size, projected growth trends, production technologies, key applications, and end-use industries.

Rilpivirine Segment by Company

Aspen

Gilead Sciences

Janssen Cilag International

Pharmacare Limited

Strides Pharma Science Limited

ViiV Healthcare

Rilpivirine Segment by Type

Self-production API

Outsourcing of API

Rilpivirine Segment by Application

Clinic

Hospital

Drug Center

Others

Rilpivirine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Rilpivirine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Rilpivirine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Rilpivirine significant trends, drivers, influence factors in global and regions.

6. To analyze Rilpivirine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rilpivirine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rilpivirine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rilpivirine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Rilpivirine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Rilpivirine industry.

Chapter 3: Detailed analysis of Rilpivirine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Rilpivirine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Rilpivirine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Rilpivirine Industry Trends Table 2. Rilpivirine Industry Drivers Table 3. Rilpivirine Industry Opportunities and Challenges Table 4. Rilpivirine Industry Restraints Table 5. Global Rilpivirine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Rilpivirine Revenue Share by Company (2021-2026) Table 7. Global Rilpivirine Sales Volume by Company (k pcs) & (2021-2026) Table 8. Global Rilpivirine Sales Volume Share by Company (2021-2026) Table 9. Global Rilpivirine Average Price (US$/pcs) of Company (2021-2026) Table 10. Global Rilpivirine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Rilpivirine Key Company Manufacturing Base & Headquarters Table 12. Global Rilpivirine Company, Product Type & Application Table 13. Global Rilpivirine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Rilpivirine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Self-production API Table 18. Significant Companies of Outsourcing of API Table 19. Global Rilpivirine Sales Volume by Type 2021 VS 2025 VS 2032 (k pcs) Table 20. Global Rilpivirine Sales Volume by Type (2021-2026) & (k pcs) Table 21. Global Rilpivirine Sales Volume by Type (2027-2032) & (k pcs) Table 22. Global Rilpivirine Sales Volume Share by Type (2021-2026) Table 23. Global Rilpivirine Sales Volume Share by Type (2027-2032) Table 24. Global Rilpivirine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Rilpivirine Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Rilpivirine Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Rilpivirine Sales Value Share by Type (2021-2026) Table 28. Global Rilpivirine Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Clinic Table 30. Significant Companies of Hospital Table 31. Significant Companies of Drug Center Table 32. Significant Companies of Others Table 33. Global Rilpivirine Sales Volume by Application 2021 VS 2025 VS 2032 (k pcs) Table 34. Global Rilpivirine Sales Volume by Application (2021-2026) & (k pcs) Table 35. Global Rilpivirine Sales Volume by Application (2027-2032) & (k pcs) Table 36. Global Rilpivirine Sales Volume Share by Application (2021-2026) Table 37. Global Rilpivirine Sales Volume Share by Application (2027-2032) Table 38. Global Rilpivirine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Rilpivirine Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Rilpivirine Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Rilpivirine Sales Value Share by Application (2021-2026) Table 42. Global Rilpivirine Sales Value Share by Application (2027-2032) Table 43. Global Rilpivirine Sales by Region: 2021 VS 2025 VS 2032 (k pcs) Table 44. Global Rilpivirine Sales by Region (2021-2026) & (k pcs) Table 45. Global Rilpivirine Sales Market Share by Region (2021-2026) Table 46. Global Rilpivirine Sales by Region (2027-2032) & (k pcs) Table 47. Global Rilpivirine Sales Market Share by Region (2027-2032) Table 48. Global Rilpivirine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Rilpivirine Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Rilpivirine Sales Value Share by Region (2021-2026) Table 51. Global Rilpivirine Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Rilpivirine Sales Value Share by Region (2027-2032) Table 53. Global Rilpivirine Market Average Price (US$/pcs) by Region (2021-2026) Table 54. Global Rilpivirine Market Average Price (US$/pcs) by Region (2027-2032) Table 55. Global Rilpivirine Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Table 56. Global Rilpivirine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Rilpivirine Sales by Country (2021-2026) & (k pcs) Table 58. Global Rilpivirine Sales Market Share by Country (2021-2026) Table 59. Global Rilpivirine Sales by Country (2027-2032) & (k pcs) Table 60. Global Rilpivirine Sales Market Share by Country (2027-2032) Table 61. Global Rilpivirine Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Rilpivirine Sales Value Market Share by Country (2021-2026) Table 63. Global Rilpivirine Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Rilpivirine Sales Value Market Share by Country (2027-2032) Table 65. Aspen Company Information Table 66. Aspen Business Overview Table 67. Aspen Rilpivirine Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 68. Aspen Rilpivirine Product Portfolio Table 69. Aspen Recent Development Table 70. Gilead Sciences Company Information Table 71. Gilead Sciences Business Overview Table 72. Gilead Sciences Rilpivirine Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 73. Gilead Sciences Rilpivirine Product Portfolio Table 74. Gilead Sciences Recent Development Table 75. Janssen Cilag International Company Information Table 76. Janssen Cilag International Business Overview Table 77. Janssen Cilag International Rilpivirine Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 78. Janssen Cilag International Rilpivirine Product Portfolio Table 79. Janssen Cilag International Recent Development Table 80. Pharmacare Limited Company Information Table 81. Pharmacare Limited Business Overview Table 82. Pharmacare Limited Rilpivirine Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 83. Pharmacare Limited Rilpivirine Product Portfolio Table 84. Pharmacare Limited Recent Development Table 85. Strides Pharma Science Limited Company Information Table 86. Strides Pharma Science Limited Business Overview Table 87. Strides Pharma Science Limited Rilpivirine Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 88. Strides Pharma Science Limited Rilpivirine Product Portfolio Table 89. Strides Pharma Science Limited Recent Development Table 90. ViiV Healthcare Company Information Table 91. ViiV Healthcare Business Overview Table 92. ViiV Healthcare Rilpivirine Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 93. ViiV Healthcare Rilpivirine Product Portfolio Table 94. ViiV Healthcare Recent Development Table 95. Key Raw Materials Table 96. Raw Materials Key Suppliers Table 97. Rilpivirine Distributors List Table 98. Rilpivirine Customers List Table 99. Research Programs/Design for This Report Table 100. Authors List of This Report Table 101. Secondary Sources Table 102. Primary Sources List of Figures Figure 1. Rilpivirine Product Image Figure 2. Global Rilpivirine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rilpivirine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Rilpivirine Sales (2021-2032) & (k pcs) Figure 5. Global Rilpivirine Sales Average Price (US$/pcs) & (2021-2032) Figure 6. Global Rilpivirine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Self-production API Image Figure 10. Outsourcing of API Image Figure 11. Global Rilpivirine Sales Volume by Type (2021 VS 2025 VS 2032) & (k pcs) Figure 12. Global Rilpivirine Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Rilpivirine Sales Volume Share by Type (2021-2032) Figure 14. Global Rilpivirine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Rilpivirine Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Rilpivirine Sales Value Share by Type (2021-2032) Figure 17. Clinic Image Figure 18. Hospital Image Figure 19. Drug Center Image Figure 20. Others Image Figure 21. Global Rilpivirine Sales Volume by Application (2021 VS 2025 VS 2032) & (k pcs) Figure 22. Global Rilpivirine Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Rilpivirine Sales Volume Share by Application (2021-2032) Figure 24. Global Rilpivirine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Rilpivirine Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Rilpivirine Sales Value Share by Application (2021-2032) Figure 27. Global Rilpivirine Sales by Region: 2021 VS 2025 VS 2032 (k pcs) Figure 28. Global Rilpivirine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Rilpivirine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Rilpivirine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Rilpivirine Sales Value (2021-2032) & (US$ Million) Figure 32. North America Rilpivirine Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Rilpivirine Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Rilpivirine Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Rilpivirine Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Rilpivirine Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Rilpivirine Sales Value (2021-2032) & (US$ Million) Figure 38. South America Rilpivirine Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Rilpivirine Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Rilpivirine Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Rilpivirine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Rilpivirine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Rilpivirine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Rilpivirine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Rilpivirine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Rilpivirine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Rilpivirine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Rilpivirine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Rilpivirine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Rilpivirine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Rilpivirine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Rilpivirine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Rilpivirine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Rilpivirine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Rilpivirine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Rilpivirine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Rilpivirine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Rilpivirine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Rilpivirine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Rilpivirine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Rilpivirine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Rilpivirine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Rilpivirine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Rilpivirine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Rilpivirine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Rilpivirine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Rilpivirine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Rilpivirine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Rilpivirine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Rilpivirine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Rilpivirine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Rilpivirine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Rilpivirine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Rilpivirine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Rilpivirine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Rilpivirine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Rilpivirine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Rilpivirine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Rilpivirine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Rilpivirine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Rilpivirine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Rilpivirine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Rilpivirine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Rilpivirine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Rilpivirine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Rilpivirine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Rilpivirine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Rilpivirine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Rilpivirine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Rilpivirine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Rilpivirine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Rilpivirine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Rilpivirine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Rilpivirine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Rilpivirine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Rilpivirine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Rilpivirine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Rilpivirine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Rilpivirine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Rilpivirine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Rilpivirine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Rilpivirine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Rilpivirine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Rilpivirine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Rilpivirine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Rilpivirine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Rilpivirine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Rilpivirine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Rilpivirine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Rilpivirine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Rilpivirine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Rilpivirine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Rilpivirine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Rilpivirine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Rilpivirine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Rilpivirine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Rilpivirine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Rilpivirine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Rilpivirine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Rilpivirine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Rilpivirine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Rilpivirine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Rilpivirine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Rilpivirine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Rilpivirine Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Rilpivirine Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Self-production API
  • Outsourcing of API
Applications
  • Clinic
  • Hospital
  • Drug Center
  • Others
Companies covered
  • Aspen
  • Gilead Sciences
  • Janssen Cilag International
  • Pharmacare Limited
  • Strides Pharma Science Limited
  • ViiV Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Rilpivirine Sales Value (2021-2032)
  4. 1.2.2 Global Rilpivirine Sales Volume (2021-2032)
  5. 1.2.3 Global Rilpivirine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Rilpivirine Market Dynamics
  1. 2.1 Rilpivirine Industry Trends
  2. 2.2 Rilpivirine Industry Drivers
  3. 2.3 Rilpivirine Industry Opportunities and Challenges
  4. 2.4 Rilpivirine Industry Restraints
3 Rilpivirine Market by Company
  1. 3.1 Global Rilpivirine Company Revenue Ranking in 2025
  2. 3.2 Global Rilpivirine Revenue by Company (2021-2026)
  3. 3.3 Global Rilpivirine Sales Volume by Company (2021-2026)
  4. 3.4 Global Rilpivirine Average Price by Company (2021-2026)
  5. 3.5 Global Rilpivirine Company Ranking (2024-2026)
  6. 3.6 Global Rilpivirine Company Manufacturing Base and Headquarters
  7. 3.7 Global Rilpivirine Company Product Type and Application
  8. 3.8 Global Rilpivirine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Rilpivirine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Rilpivirine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Rilpivirine Market by Type
  1. 4.1 Rilpivirine Type Introduction
  2. 4.1.1 Self-production API
  3. 4.1.2 Outsourcing of API
  4. 4.2 Global Rilpivirine Sales Volume by Type
  5. 4.2.1 Global Rilpivirine Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Rilpivirine Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Rilpivirine Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Rilpivirine Sales Value by Type
  9. 4.3.1 Global Rilpivirine Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Rilpivirine Sales Value by Type (2021-2032)
  11. 4.3.3 Global Rilpivirine Sales Value Share by Type (2021-2032)
5 Rilpivirine Market by Application
  1. 5.1 Rilpivirine Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Drug Center
  5. 5.1.4 Others
  6. 5.2 Global Rilpivirine Sales Volume by Application
  7. 5.2.1 Global Rilpivirine Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Rilpivirine Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Rilpivirine Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Rilpivirine Sales Value by Application
  11. 5.3.1 Global Rilpivirine Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Rilpivirine Sales Value by Application (2021-2032)
  13. 5.3.3 Global Rilpivirine Sales Value Share by Application (2021-2032)
6 Rilpivirine Regional Sales and Value Analysis
  1. 6.1 Global Rilpivirine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Rilpivirine Sales by Region (2021-2032)
  3. 6.2.1 Global Rilpivirine Sales by Region: 2021-2026
  4. 6.2.2 Global Rilpivirine Sales by Region (2027-2032)
  5. 6.3 Global Rilpivirine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Rilpivirine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Rilpivirine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Rilpivirine Sales Value by Region (2027-2032)
  9. 6.5 Global Rilpivirine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Rilpivirine Sales Value (2021-2032)
  12. 6.6.2 North America Rilpivirine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Rilpivirine Sales Value (2021-2032)
  15. 6.7.2 Europe Rilpivirine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Rilpivirine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Rilpivirine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Rilpivirine Sales Value (2021-2032)
  21. 6.9.2 South America Rilpivirine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Rilpivirine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Rilpivirine Sales Value Share by Country, 2025 VS 2032
7 Rilpivirine Country-level Sales and Value Analysis
  1. 7.1 Global Rilpivirine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Rilpivirine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Rilpivirine Sales by Country (2021-2032)
  4. 7.3.1 Global Rilpivirine Sales by Country (2021-2026)
  5. 7.3.2 Global Rilpivirine Sales by Country (2027-2032)
  6. 7.4 Global Rilpivirine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Rilpivirine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Rilpivirine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Rilpivirine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Rilpivirine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Rilpivirine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Rilpivirine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Rilpivirine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Rilpivirine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Rilpivirine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Rilpivirine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Rilpivirine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Rilpivirine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Rilpivirine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Rilpivirine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Rilpivirine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Rilpivirine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Rilpivirine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Rilpivirine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Rilpivirine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Rilpivirine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Rilpivirine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Rilpivirine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Rilpivirine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Rilpivirine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Rilpivirine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Rilpivirine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Rilpivirine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Rilpivirine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Rilpivirine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Rilpivirine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Rilpivirine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Rilpivirine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Rilpivirine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Rilpivirine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Rilpivirine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Rilpivirine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Rilpivirine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Rilpivirine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Rilpivirine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Rilpivirine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Rilpivirine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Rilpivirine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Rilpivirine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Rilpivirine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Rilpivirine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Rilpivirine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Rilpivirine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Rilpivirine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Rilpivirine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Rilpivirine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Rilpivirine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Rilpivirine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Rilpivirine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Rilpivirine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Rilpivirine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Rilpivirine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Rilpivirine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Rilpivirine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Rilpivirine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Rilpivirine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Rilpivirine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Rilpivirine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Rilpivirine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Rilpivirine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Rilpivirine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Rilpivirine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Rilpivirine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Rilpivirine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Rilpivirine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Rilpivirine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Rilpivirine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Rilpivirine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Rilpivirine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Rilpivirine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Rilpivirine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Rilpivirine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Rilpivirine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Rilpivirine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Rilpivirine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Rilpivirine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Rilpivirine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Rilpivirine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Rilpivirine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Rilpivirine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Rilpivirine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Rilpivirine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Aspen
  2. 8.1.1 Aspen Company Information
  3. 8.1.2 Aspen Business Overview
  4. 8.1.3 Aspen Rilpivirine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Aspen Rilpivirine Product Portfolio
  6. 8.1.5 Aspen Recent Developments
  7. 8.2 Gilead Sciences
  8. 8.2.1 Gilead Sciences Company Information
  9. 8.2.2 Gilead Sciences Business Overview
  10. 8.2.3 Gilead Sciences Rilpivirine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Gilead Sciences Rilpivirine Product Portfolio
  12. 8.2.5 Gilead Sciences Recent Developments
  13. 8.3 Janssen Cilag International
  14. 8.3.1 Janssen Cilag International Company Information
  15. 8.3.2 Janssen Cilag International Business Overview
  16. 8.3.3 Janssen Cilag International Rilpivirine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Janssen Cilag International Rilpivirine Product Portfolio
  18. 8.3.5 Janssen Cilag International Recent Developments
  19. 8.4 Pharmacare Limited
  20. 8.4.1 Pharmacare Limited Company Information
  21. 8.4.2 Pharmacare Limited Business Overview
  22. 8.4.3 Pharmacare Limited Rilpivirine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Pharmacare Limited Rilpivirine Product Portfolio
  24. 8.4.5 Pharmacare Limited Recent Developments
  25. 8.5 Strides Pharma Science Limited
  26. 8.5.1 Strides Pharma Science Limited Company Information
  27. 8.5.2 Strides Pharma Science Limited Business Overview
  28. 8.5.3 Strides Pharma Science Limited Rilpivirine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Strides Pharma Science Limited Rilpivirine Product Portfolio
  30. 8.5.5 Strides Pharma Science Limited Recent Developments
  31. 8.6 ViiV Healthcare
  32. 8.6.1 ViiV Healthcare Company Information
  33. 8.6.2 ViiV Healthcare Business Overview
  34. 8.6.3 ViiV Healthcare Rilpivirine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 ViiV Healthcare Rilpivirine Product Portfolio
  36. 8.6.5 ViiV Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Rilpivirine Value Chain Analysis
  2. 9.1.1 Rilpivirine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Rilpivirine Sales Mode & Process
  6. 9.2 Rilpivirine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Rilpivirine Distributors
  9. 9.2.3 Rilpivirine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst